Media & Press Enquiries: press@healthnethomecare.co.uk
Pharmacovigilance and Compliance in Clinical Homecare
Patient safety, regulatory compliance, and transparency are fundamental to HealthNet’s clinical homecare services. We operate robust pharmacovigilance (PV) and compliance frameworks to ensure medicines supplied and supported in the community meet all applicable regulatory, ethical, and governance standards.
Our approach reflects the shared responsibilities between pharmaceutical companies, NHS organisations, and homecare providers, supporting safe use of medicines while maintaining clear accountability.
Our Approach to Pharmacovigilance
HealthNet plays an active role in pharmacovigilance as part of the wider medicines safety system. We support the identification, documentation, and reporting of safety information associated with medicines used within our services.
This includes:
Capturing adverse events (AEs) and adverse drug reactions (ADRs) reported by patients, carers, or healthcare professionals
Recognising and escalating product complaints and safety concerns
Ensuring information is handled in line with agreed reporting timelines and contractual requirements
Pharmacovigilance activities are delivered in line with applicable UK regulatory requirements and client‑specific agreements.
Reporting and Escalation Processes
Clear and auditable reporting pathways are in place to support timely escalation of safety information:
All relevant staff are trained to recognise potential safety events
Reportable information is documented accurately and escalated without delay
Reports are shared with the appropriate pharmaceutical company, NHS organisation, or regulatory body in line with agreed protocols
These processes support early risk identification and ongoing patient safety monitoring.
Compliance and Regulatory Governance
HealthNet operates within a comprehensive compliance framework designed to support medicines safety and service assurance. This includes adherence to:
UK medicines regulations and applicable national guidance
NHS England expectations for medicines homecare services
ABPI‑compliant service delivery models
Data protection and information governance requirements
Our policies, procedures, and systems are regularly reviewed to ensure alignment with regulatory and contractual obligations.
Training and Awareness
Maintaining a strong compliance culture depends on staff knowledge and accountability. We ensure that:
Employees receive mandatory training in pharmacovigilance, complaints handling, and governance
Role‑specific training is provided for clinical, operational, and patient‑facing teams
Refresher training and updates are delivered to reflect regulatory or procedural changes
This ensures staff understand their responsibilities and act consistently across services.
Partnership with Clients and the NHS
Pharmacovigilance and compliance are delivered collaboratively. HealthNet works closely with:
Pharmaceutical partners to meet contractual PV obligations
NHS Trusts and Integrated Care Boards (ICBs) to support shared‑care pathways
Clinical teams to ensure safety information is communicated clearly and appropriately
This partnership model supports confidence in service delivery and regulatory assurance.
Continuous Improvement and Audit
We use governance processes to continuously strengthen our pharmacovigilance and compliance arrangements, including:
Internal audits and quality reviews
Monitoring of incidents, near misses, and trends
Implementation of corrective and preventive actions (CAPAs)
Learning from experience is used to enhance service reliability and patient safety over time.

Our Commitment
Through strong pharmacovigilance and compliance frameworks, HealthNet supports the safe and effective use of medicines in the home, protecting patients and supporting our partners’ regulatory responsibilities.
For further information on our pharmacovigilance or compliance arrangements, please contact your HealthNet Business Development Manager or email client.services@healthnethomecare.co.uk.
